Company Encyclopedia
View More
name
BJ HEALTH
02389.HK
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial park and incubator projects; sports businesses, which includes construction and operation of stadiums for winter sports; and investment in the field of the biotechnology, pharmaceutical, medical services, and medical travel. The company also provides investment management consulting services; and engages in trading geriatric care related furniture. In addition, it is involved in medical and logistics related property development activities.
52.63 B
02389.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking12/28
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-5.09%D
    • Profit Margin-58.11%E
    • Gross Margin26.63%C
  • Growth ScoreC
    • Revenue YoY12.99%B
    • Net Profit YoY12.94%C
    • Total Assets YoY-5.54%D
    • Net Assets YoY-6.10%D
  • Cash ScoreC
    • Cash Flow Margin-172.08%D
    • OCF YoY12.99%B
  • Operating ScoreE
    • Turnover0.08E
  • Debt ScoreA
    • Gearing Ratio10.39%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    BJ HEALTH: Xiao Jianwei resigns as executive director

    According to a notice released by BJ HEALTH, Mr. Xiao Jianwei has resigned as the company's executive director, effective from October 10, 2025, due to the regulatory actions and related outcomes concerning him by the Stock Exchange

    Zhitong·
    HK
    02389
    -2.67%
    Zhitong·
    HK
    02389
    -2.67%

    BJ HEALTH released its interim results, with a loss attributable to shareholders of HKD 29.236 million, a year-on-year decrease of 48.17%

    BJ HEALTH released its interim results for the period ending June 30, 2025, with revenue of HKD 76.587 million, an increase of 4.47% year-on-year; the loss attributable to shareholders was HKD 29.236 million, a decrease of 48.17% year-on-year; basic loss per share was HKD 0.048. The revenue growth was mainly due to moderate growth in medical and elderly care products, particularly strong sales performance in the educational furniture product line

    Zhitong·
    HK
    02389
    -2.67%
    Zhitong·
    HK
    02389
    -2.67%

    BJ HEALTH subsidiary wins the bid for the elderly service center project in Guangde City, Anhui Province

    BJ HEALTH's subsidiary, Wuxi Beikang Hongtai Elderly Care Service Co., Ltd., successfully won the bid for the elderly care service center project in Guangde City, Anhui Province. The project has a construction area of approximately 10,000 square meters and is designed to have about 290 beds, funded by the Guangde City government. The project is expected to take 16 months to prepare and aims to meet the elderly care needs in the Yangtze River Delta region. After winning the bid, the number of care institutions under the group increased to 9, with a total of 2,138 beds

    Zhitong·
    HK
    02389
    -2.67%
    Zhitong·
    HK
    02389
    -2.67%

    BJ HEALTH released its annual performance report, with a loss attributable to shareholders of HKD 116 million, an increase of 87.81% year-on-year

    According to the Zhitong Finance APP, BJ HEALTH released its annual performance for the year ending December 31, 2024, with group revenue of HKD 150 million, a year-on-year increase of 6.84%; the loss attributable to shareholders was HKD 116 million, an increase of 87.81% year-on-year; the loss per share was HKD 1.92

    Zhitong·
    HK
    02389
    -2.67%
    Zhitong·
    HK
    02389
    -2.67%

    BJ HEALTH issued a profit warning, expecting the annual loss attributable to shareholders to increase year-on-year

    BJ HEALTH issued a profit warning, expecting the annual loss attributable to shareholders for the year ending December 31, 2024, to increase by approximately HKD 55 million compared to the previous year. The increase in loss is mainly due to foreign exchange losses, impairment provisions resulting from the decline in the stock prices of listed joint ventures, increased losses from joint ventures, and impairment of other receivables

    Zhitong·
    HK
    02389
    -2.67%
    Zhitong·
    HK
    02389
    -2.67%
    © 2025 Longbridge｜Disclaimer